Abstract:Alzheimer's disease is increasingly considered a large-scale network disconnection syndrome, associated with progressive aggregation of pathological proteins, cortical atrophy, and functional disconnections between brain regions. These pathological changes are posited to arise in a stereotypical spatiotemporal manner, targeting intrinsic networks in the brain, most notably the default mode network. While this network-specific disruption has been thoroughly studied with functional neuroimaging, changes to specific white matter fibre pathways within the brain's structural networks have not been closely investigated, largely due to the challenges of modelling complex white matter structure. Here, we applied a novel technique known as 'fixel-based analysis' to comprehensively investigate fibre tract-specific differences at a within-voxel level (called 'fixels') to assess potential axonal loss in subjects with Alzheimer's disease and mild cognitive impairment. We hypothesized that patients with Alzheimer's disease would exhibit extensive degeneration across key fibre pathways connecting default network nodes, while patients with mild cognitive impairment would exhibit selective degeneration within fibre pathways connecting regions previously identified as functionally implicated early in Alzheimer's disease. Diffusion MRI data from Alzheimer's disease (n = 49), mild cognitive impairment (n = 33), and healthy elderly control subjects (n = 95) were obtained from the Australian Imaging, Biomarkers and Lifestyle study of ageing. We assessed microstructural differences in fibre density, and macrostructural differences in fibre bundle morphology using fixel-based analysis. Whole-brain analysis was performed to compare groups across all white matter fixels. Subsequently, we performed a tract of interest analysis comparing fibre density and cross-section across 11 selected white matter tracts, to investigate potentially subtle degeneration within fibre pathways in mild cognitive impairment, initially by clinical diagnosis alone, and then by including amyloid status (i.e. a positive or negative amyloid PET scan). Our whole-brain analysis revealed significant white matter loss manifesting both microstructurally and macrostructurally in Alzheimer's disease patients, evident in specific fibre pathways associated with default mode network nodes. Reductions in fibre density and cross-section in mild cognitive impairment patients were only exhibited within the posterior cingulum when statistical analyses were limited to tracts of interest. Interestingly, these degenerative changes did not appear to be associated with high amyloid accumulation, given that amyloid-negative, but not positive, mild cognitive impairment subjects exhibited subtle focal left posterior cingulum deficits. The findings of this study demonstrated a stereotypical distribution of white matter degeneration in patients with Alzheimer's disease, which was in line with canonical findings from other imaging modalities, and with a network-based conceptualization of the disease.awx355media15726254535001.

White matter changes in Alzheimer’s disease: a focus on myelin and oligodendrocytes

Progress in molecular mechanisms of β-amyloid peptides in alzheimer's disease

Characterization of Local White Matter Microstructural Alterations in Alzheimer’s Disease: A Reproducible Study

Association of Amyloid Pathology With Myelin Alteration in Preclinical Alzheimer Disease

Alzheimer's-linked axonal changes accompany elevated antidromic action potential failure rate in aged mice

Oligodendrocytes and Alzheimer's disease

Temporal Alterations in White Matter in An App Knock-In Mouse Model of Alzheimers Disease

Dynamic changes in myelin aberrations and oligodendrocyte generation in chronic amyloidosis in mice and men

White Matter Injury, Cholesterol Dysmetabolism, and APP/Abeta Dysmetabolism Interact to Produce Alzheimer’s Disease (AD) Neuropathology: A Hypothesis and Review

White Matter Damage of Patients with Alzheimer’s Disease Correlated with the Decreased Cognitive Function

Myelin dysfunction drives amyloid-β deposition in models of Alzheimer’s disease

Transcriptomic, Cellular, and Functional Signatures of White Matter Damage in Alzheimer’s Disease

Influences of amyloid-β and tau on white matter neurite alterations in dementia with Lewy bodies

Abnormal white matter changes in Alzheimer's disease based on diffusion tensor imaging: A systematic review

Myelin injury and degraded myelin vesicles in Alzheimer's disease.

White matter injury, cholesterol dysmetabolism, and APP/Abeta dysmetabolism interact to produce Alzheimer's disease (AD) neuropathology: A hypothesis and review

Early Oligodendrocyte/Myelin Pathology in Alzheimer's Disease Mice Constitutes a Novel Therapeutic Target

Oligodendrocytes damage in Alzheimer's disease: Beta amyloid toxicity and inflammation

Fibre-specific white matter reductions in Alzheimer’s disease and mild cognitive impairment

Association between brain amyloid deposition and longitudinal changes of white matter hyperintensities

Oligodendrocytes Play a Critical Role in White Matter Damage of Vascular Dementia